SciClone Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

SciClone Pharmaceuticals M&A Summary

SciClone Pharmaceuticals has acquired 1 company of its own. A total of 1 acquisition came from private equity firms.

The Company’s most targeted sectors include life science (100%).

SciClone Pharmaceuticals Ownership

Who owns SciClone Pharmaceuticals?

SciClone Pharmaceuticals is owned by Ascendent Capital Partners. It was acquired on June 8, 2017.

Is SciClone Pharmaceuticals PE-backed?

Yes. SciClone Pharmaceuticals is owned by private equity investor Ascendent Capital Partners.

SciClone Pharmaceuticals Business Overview

Where is SciClone Pharmaceuticals headquartered?

SciClone Pharmaceuticals is headquartered in Foster City, California.

What is SciClone Pharmaceuticals’ revenue?

SciClone Pharmaceuticals disclosed revenue of 160M USD for 2016 and 157M USD for 2015.

How many employees does SciClone Pharmaceuticals have?

SciClone Pharmaceuticals has 570 employees.

What sector is SciClone Pharmaceuticals in?

SciClone Pharmaceuticals is a life science company.

When was SciClone Pharmaceuticals founded?

SciClone Pharmaceuticals was founded in 1989.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

SciClone Pharmaceuticals

SciClone Pharmaceuticals, Inc.

950 Tower Lane, Suite 900,
Foster City, California 94404
United States,
(650) 358-3456
www.sciclone.com

SciClone Pharmaceuticals is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. SciClone's proprietary lead product, ZADAXIN® (thymalfasin), is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as an immune system enhancer, according to the local regulatory approvals. SciClone Pharmaceuticals was founded in 1989 and is based in Foster City, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
NovaMed Pharmaceuticals 2011-04-19 - Add-on Acquisition
Shanghai, China · www.novamed.com.cn
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
China 1 - - -
Total 1 - - -

M&A Connections

Deals
Acquired from
Investor(s)
100%
1 (100%)

 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.